AI-powered nodule detection, reporting, and patient management for enhanced
efficiency and accuracy in lung cancer diagnosis
DeepHealth Lung is an AI-powered solution designed to enhance
lung cancer
diagnosis and reporting. It integrates seamlessly into existing Picture Archiving and
Communication Systems (PACS), offering both onsite and cloud deployment options to minimize
workflow disruptions. Trained on over 40,000 scans, DeepHealth Lung automates the detection,
classification, quantification, and growth assessment of pulmonary nodules, identifying
solid
and sub-solid nodules ranging from 3 to 30mm with 95% sensitivity and no more than two false
positives per scan.
The system provides accurate measurements of nodule diameters
and volumes, and can automatically retrieve prior scans to calculate growth percentage and
volume doubling time. Widely adopted across nearly 100 locations in the UK and EU, including
41 out
of 45 sites in the UK’s Targeted Lung Health Checks program, DeepHealth Lung processes over
50,000 scans monthly, delivering standardized, customizable, and shareable lung nodule
reports to support
efficient clinical workflows.
“I have reduced my chest CT reporting time by
about 50%. The volumetry is also fantastic; it saves me from manually performing the
analysis. Ultimately, a much more robust nodule follow-up –in half the time.”
Dr. Katharine Johnson
Consultant Radiologist at Salisbury NHS (UK)
“I love the detection indications. It’s a simple
yet effective solution that really helps me to report nodules faster. I know exactly where
to find them.”
Dr. Caroline McCann
Responsible Radiologist, Liverpool Heart and Chest Hospital (UK)
Please accept
statistics and marketing
cookies to watch this video. Change consent
Beyond The Diagnosis: Transforming Cancer Care Through
Innovation
Find out how those who live with and work with cancer are rewriting the
narrative in a brand-new digital series presented by Union for International Cancer Control and
produced for them by BBC StoryWorks Commercial Productions.
The series explores innovative solutions for cancer prevention, diagnosis,
treatment and care, and spotlights DeepHealth’s role in transforming lung cancer screening.
November 11, 2024: Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging.
DeepHealth returns to Nashville in the spring, this time for RBMA PaRADigm: Illustrate Ingenuity. DeepHealth is a proud sponsor of the premier annual conference for radiology business professionals and executives. Join us as we share our innovative approaches, and how DeepHealth drives breakthrough solutions for sustainable growth as an enterprise.
Join DeepHealth at the 25th Anniversary of Imagine’s Software Client Congress. Discover how our AI-powered radiology solutions complement and integrate with Imagine’s billing and revenue cycle management platform. Our team will demonstrate how our advanced algorithms support more precise coding and documentation, helping to optimize reimbursement and reduce denials.
Disclaimers:
DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc., and
DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please contact us.